The Lancet Haematology
Fecha de publicación: 12 june 2018
Autores: Gita Thanarajasingam, MD., Lori M Minasian, MD., Prof Frederic Baron, MD., Prof Franco Cavalli, MD., R Angelo De Claro, MD., Amylou C Dueck, PhD.
Background: Tremendous progress in treatment and outcomes has been achieved across the whole range of haematological malignancies in the past two decades. Although cure rates for aggressive malignancies have increased, nowhere has progress been more impactful than in the management of typically incurable forms of haematological cancer.